Abnormal expression of paxillin correlates with tumor progression and poor survival in patients with gastric cancer

Journal of Translational Medicine

Volumn 11, Issue 1, 2013, Pages

  Chen, Dong liang ^a   Wang, Zhi qiang ^a   Ren, Chao ^a   Zeng, Zhao lei ^a   Wang, De shen ^a   Luo, Hui yan ^a   Wang, Feng ^a   Qiu, Miao zhen ^a   Bai, Long ^a   Zhang, Dong sheng ^a   Wang, Feng hua ^a   Li, Yu hong ^a   Xu, Rui hua ^a  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

Author keywords

Gastric cancer; Paxillin; Prognosis; Tumor progression

Indexed keywords

FLUOROURACIL; PAXILLIN; PLATINUM COMPLEX; TAXANE DERIVATIVE;

ADJUVANT THERAPY; ADULT; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; CELL MIGRATION; CELL PROLIFERATION; CLINICAL FEATURE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISTANT METASTASIS; EPITHELIUM CELL; FEMALE; GASTRECTOMY; GENE OVEREXPRESSION; GENE SILENCING; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INHIBITION KINETICS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; STOMACH CANCER; STOMACH CARCINOGENESIS; STOMACH EPITHELIUM; UPREGULATION; WESTERN BLOTTING;

ADULT; AGED; BASE SEQUENCE; BLOTTING, WESTERN; CELL LINE, TUMOR; DISEASE PROGRESSION; DNA PRIMERS; FEMALE; HUMANS; MALE; MIDDLE AGED; PAXILLIN; REAL-TIME POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS; SURVIVAL RATE;

EID: 84886730888     PISSN: None     EISSN: 14795876     Source Type: Journal    
DOI: 10.1186/1479-5876-11-277     Document Type: Article

References (33)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Kamangar F, Dores GM, Anderson WF. Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world. J Clin Oncol 2006, 24:2137-2150. 10.1200/JCO.2005.05.2308, 16682732.
3. Cunningham D, Allum WH, Stenning SP, Thompson JN, Van de Velde CJ, Nicolson M, Scarffe JH, Lofts FJ, Falk SJ, Iveson TJ, et al. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer. N Engl J Med 2006, 355:11-20. 10.1056/NEJMoa055531, 16822992.
4. Glenney JR, Zokas L. Novel tyrosine kinase substrates from Rous sarcoma virus-transformed cells are present in the membrane skeleton. J Cell Biol 1989, 108:2401-2408. 10.1083/jcb.108.6.2401, 2115592, 2472406.
5. Turner CE. Paxillin interactions. J Cell Sci 2000, 113(Pt 23):4139-4140.
6. Schaller MD. Paxillin: a focal adhesion-associated adaptor protein. Oncogene 2001, 20:6459-6472. 10.1038/sj.onc.1204786, 11607845.
7. Turner CE. Paxillin and focal adhesion signalling. Nat Cell Biol 2000, 2:E231-E236. 10.1038/35046659, 11146675.
8. Brown MC, Turner CE. Paxillin: adapting to change. Physiol Rev 2004, 84:1315-1339. 10.1152/physrev.00002.2004, 15383653.
9. Salgia R, Uemura N, Okuda K, Li JL, Pisick E, Sattler M, de Jong R, Druker B, Heisterkamp N, Chen LB, et al. CRKL links p210BCR/ABL with paxillin in chronic myelogenous leukemia cells. J Biol Chem 1995, 270:29145-29150. 10.1074/jbc.270.49.29145, 7493940.
10. Ma PC, Kijima T, Maulik G, Fox EA, Sattler M, Griffin JD, Johnson BE, Salgia R. c-MET mutational analysis in small cell lung cancer: novel juxtamembrane domain mutations regulating cytoskeletal functions. Cancer Res 2003, 63:6272-6281.
11. Maulik G, Kijima T, Ma PC, Ghosh SK, Lin J, Shapiro GI, Schaefer E, Tibaldi E, Johnson BE, Salgia R. Modulation of the c-Met/hepatocyte growth factor pathway in small cell lung cancer. Clin Cancer Res 2002, 8:620-627.
12. Tong X, Salgia R, Li JL, Griffin JD, Howley PM. The bovine papillomavirus E6 protein binds to the LD motif repeats of paxillin and blocks its interaction with vinculin and the focal adhesion kinase. J Biol Chem 1997, 272:33373-33376. 10.1074/jbc.272.52.33373, 9407131.
13. Salgia R, Li JL, Lo SH, Brunkhorst B, Kansas GS, Sobhany ES, Sun Y, Pisick E, Hallek M, Ernst T, et al. Molecular cloning of human paxillin, a focal adhesion protein phosphorylated by P210BCR/ABL. J Biol Chem 1995, 270:5039-5047. 10.1074/jbc.270.10.5039, 7534286.
14. Salgia R, Li JL, Ewaniuk DS, Wang YB, Sattler M, Chen WC, Richards W, Pisick E, Shapiro GI, Rollins BJ, et al. Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene 1999, 18:67-77. 10.1038/sj.onc.1202273, 9926921.
15. Wu DW, Cheng YW, Wang J, Chen CY, Lee H. Paxillin predicts survival and relapse in non-small cell lung cancer by microRNA-218 targeting. Cancer Res 2010, 70:10392-10401. 10.1158/0008-5472.CAN-10-2341, 21159652.
16. Jagadeeswaran R, Surawska H, Krishnaswamy S, Janamanchi V, Mackinnon AC, Seiwert TY, Loganathan S, Kanteti R, Reichman T, Nallasura V, et al. Paxillin is a target for somatic mutations in lung cancer: implications for cell growth and invasion. Cancer Res 2008, 68:132-142. 10.1158/0008-5472.CAN-07-1998, 2767335, 18172305.
17. Mackinnon AC, Tretiakova M, Henderson L, Mehta RG, Yan BC, Joseph L, Krausz T, Husain AN, Reid ME, Salgia R. Paxillin expression and amplification in early lung lesions of high-risk patients, lung adenocarcinoma and metastatic disease. J Clin Pathol 2011, 64:16-24. 10.1136/jcp.2010.075853, 3002839, 21045234.
18. Sen A, De Castro I, Defranco DB, Deng FM, Melamed J, Kapur P, Raj GV, Rossi R, Hammes SR. Paxillin mediates extranuclear and intranuclear signaling in prostate cancer proliferation. J Clin Invest 2012, 122:2469-2481. 10.1172/JCI62044, 3386821, 22684108.
19. Jun Q, Zhiwei W, Lilin M, Jing K, Qichao N. Effects of paxillin on HCT-8 human colorectal cancer cells. Hepatogastroenterology 2011, 58:1951-1955.
20. McCormack SJ, Brazinski SE, Moore JL, Werness BA, Goldstein DJ. Activation of the focal adhesion kinase signal transduction pathway in cervical carcinoma cell lines and human genital epithelial cells immortalized with human papillomavirus type 18. Oncogene 1997, 15:265-274. 10.1038/sj.onc.1201186, 9233761.
21. Li D, Ding J, Wang X, Wang C, Wu T. Fibronectin promotes tyrosine phosphorylation of paxillin and cell invasiveness in the gastric cancer cell line AGS. Tumori 2009, 95:769-779.
22. Teng KY, Qiu MZ, Li ZH, Luo HY, Zeng ZL, Luo RZ, Zhang HZ, Wang ZQ, Li YH, Xu RH. DNA polymerase eta protein expression predicts treatment response and survival of metastatic gastric adenocarcinoma patients treated with oxaliplatin-based chemotherapy. J Transl Med 2010, 8:126. 10.1186/1479-5876-8-126, 3003639, 21110884.
23. Zeng ZL, Wu WJ, Yang J, Tang ZJ, Chen DL, Qiu MZ, Luo HY, Wang ZQ, Jin Y, Wang DS, Xu RH. Prognostic relevance of melanoma antigen D1 expression in colorectal carcinoma. J Transl Med 2012, 10:181. 10.1186/1479-5876-10-181, 3494540, 22935435.
24. Wang H, Wu J, Meng X, Ying X, Zuo Y, Liu R, Pan Z, Kang T, Huang W. MicroRNA-342 inhibits colorectal cancer cell proliferation and invasion by directly targeting DNA methyltransferase 1. Carcinogenesis 2011, 32:1033-1042. 10.1093/carcin/bgr081, 21565830.
25. Chen DL, Zeng ZL, Yang J, Ren C, Wang DS, Wu WJ, Xu RH. L1cam promotes tumor progression and metastasis and is an independent unfavorable prognostic factor in gastric cancer. J Hematol Oncol 2013, 6:43. 10.1186/1756-8722-6-43, 3717076, 23806079.
26. Chen DL, Wang DS, Wu WJ, Zeng ZL, Luo HY, Qiu MZ, Ren C, Zhang DS, Wang ZQ, Wang FH, et al. Overexpression of paxillin induced by miR-137 suppression promotes tumor progression and metastasis in colorectal cancer. Carcinogenesis 2013, 34:803-811. 10.1093/carcin/bgs400, 3616669, 23275153.
27. Sen A, O'Malley K, Wang Z, Raj GV, Defranco DB, Hammes SR. Paxillin regulates androgen- and epidermal growth factor-induced MAPK signaling and cell proliferation in prostate cancer cells. J Biol Chem 2010, 285:28787-28795. 10.1074/jbc.M110.134064, 2937906, 20628053.
28. Li HG, Xie DR, Shen XM, Li HH, Zeng H, Zeng YJ. Clinicopathological significance of expression of paxillin, syndecan-1 and EMMPRIN in hepatocellular carcinoma. World J Gastroenterol 2005, 11:1445-1451.
29. Shi J, Wang S, Zhao E, Shi L, Xu X, Fang M. Paxillin expression levels are correlated with clinical stage and metastasis in salivary adenoid cystic carcinoma. J Oral Pathol Med 2010, 39:548-551.
30. Panetti TS. Tyrosine phosphorylation of paxillin, FAK, and p130CAS: effects on cell spreading and migration. Front Biosci 2002, 7:d143-d150. 10.2741/panetti, 11779709.
31. Schaller MD, Schaefer EM. Multiple stimuli induce tyrosine phosphorylation of the Crk-binding sites of paxillin. Biochem J 2001, 360:57-66. 10.1042/0264-6021:3600057, 1222202, 11695992.
32. Chen HY, Shen CH, Tsai YT, Lin FC, Huang YP, Chen RH. Brk activates rac1 and promotes cell migration and invasion by phosphorylating paxillin. Mol Cell Biol 2004, 24:10558-10572. 10.1128/MCB.24.24.10558-10572.2004, 533963, 15572663.
33. Downey C, Craig DH, Basson MD. Pressure activates colon cancer cell adhesion via paxillin phosphorylation, Crk, Cas, and Rac1. Cell Mol Life Sci 2008, 65:1446-1457. 10.1007/s00018-008-8038-x, 18392556.